VEGFA and Abnormal retinal morphology: We found 21% of eyes that started VEGF inhibitors between 2015–2019 for all retinal diseases were lost to follow-up before the 12 month’s visit, with increased attrition in eyes starting treatment in 2019 which were definitely affected by COVID-19 pandemic.